AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. With origins in the UK and Sweden, it was established in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is publicly traded and has a diverse ownership structure, with no single majority stakeholder. Operating in over 100 countries, AstraZeneca primarily targets therapeutic areas such as oncology, cardiovascular, renal, metabolism, and respiratory diseases. Their commitment to advancing science and medicine has positioned them among the top pharmaceutical companies in the world.